Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,041
Closed -$78.7K 3223
2026
Q1
$78.7K Buy
1,041
+985
+1,759% +$74.1K ﹤0.01% 1121
2025
Q4
$4.17K Hold
56
﹤0.01% 2271
2025
Q3
$3.78K Buy
56
+3
+6% +$199 ﹤0.01% 2238
2025
Q2
$3.45K Sell
53
-56
-51% -$3.36K ﹤0.01% 2204
2025
Q1
$6.73K Buy
109
+59
+118% +$3.91K ﹤0.01% 1989
2024
Q4
$3.6K Sell
50
-5
-9% -$391 ﹤0.01% 2056
2024
Q3
$4.48K Buy
+55
New +$4.4K ﹤0.01% 2004
2024
Q2
Sell
-12
Closed -$936 2028
2024
Q1
$936 Buy
+12
New +$893 ﹤0.01% 2235
2022
Q4
$111K Buy
+1,478
New +$105K 0.01% 699
2022
Q3
Sell
-64
Closed -$4K 1187
2022
Q2
$4K Buy
+64
New +$4.75K ﹤0.01% 1717
2022
Q1
Sell
-16,263
Closed -$1.25M 1196
2021
Q4
$1.25M Buy
+16,263
New +$1.2M 0.08% 189

Other funds holding HOLX

CoreCap Advisors's HOLX Position: Q2 2026 in Review

CoreCap Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,041 shares — an estimated $78.7K sold.

CoreCap Advisors first reported a position in HOLX in Q4 2021 and held it in 11 quarters. The position peaked at $1.25M in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • CoreCap Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • CoreCap Advisors sold 1,041 Hologic shares in Q2 2026, an estimated $78.7K.
  • CoreCap Advisors first reported a position in Hologic in Q4 2021 and held it in 11 quarters.
  • CoreCap Advisors's Hologic position peaked at $1.25M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.